MUC6 and neoplasm: For example, Yamanoi et al. [18] reported that diminished αGlcNAc expression on MUC6 in precancerous lesions in the stomach (gastric gland mucin), pancreas (IPMNs), and esophagus (Barrett’s esophagus) is an early event indicative of tumor progression.